• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

作者信息

Bhatt Deepak L, Scheiman James, Abraham Neena S, Antman Elliott M, Chan Francis K L, Furberg Curt D, Johnson David A, Mahaffey Kenneth W, Quigley Eamonn M, Harrington Robert A, Bates Eric R, Bridges Charles R, Eisenberg Mark J, Ferrari Victor A, Hlatky Mark A, Kaul Sanjay, Lindner Jonathan R, Moliterno David J, Mukherjee Debabrata, Schofield Richard S, Rosenson Robert S, Stein James H, Weitz Howard H, Wesley Deborah J

机构信息

American College of Gastroenterology, USA.

出版信息

Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3.

DOI:10.1111/j.1572-0241.2008.02216.x
PMID:18853965
Abstract
摘要

相似文献

1
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.美国心脏病学会基金会/美国胃肠病学会/美国心脏协会2008年关于降低抗血小板治疗和非甾体抗炎药使用的胃肠道风险的专家共识文件。
Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3.
2
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.美国心脏病学会基金会临床专家共识文件特别工作组报告：ACCF/ACG/AHA 2008年关于降低抗血小板治疗和非甾体抗炎药使用的胃肠道风险的专家共识文件
J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002.
3
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.美国心脏病学会基金会临床专家共识文件特别工作组报告：ACCF/ACG/AHA 2008年关于降低抗血小板治疗和使用非甾体抗炎药胃肠道风险的专家共识文件
Circulation. 2008 Oct 28;118(18):1894-909. doi: 10.1161/CIRCULATIONAHA.108.191087. Epub 2008 Oct 3.
4
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.美国心脏病学会基金会/美国胃肠病学会/美国心脏协会2010年质子泵抑制剂与噻吩并吡啶类药物联合使用专家共识文件：ACCF/ACG/AHA 2008年关于降低抗血小板治疗和非甾体抗炎药使用的胃肠道风险专家共识文件的重点更新。美国心脏病学会基金会专家共识文件特别工作组报告。
J Am Coll Cardiol. 2010 Dec 7;56(24):2051-66. doi: 10.1016/j.jacc.2010.09.010.
5
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.ACCF/ACG/AHA 2010质子泵抑制剂与噻吩吡啶类药物联合使用专家共识文件：ACCF/ACG/AHA 2008关于降低抗血小板治疗和使用非甾体抗炎药胃肠道风险的专家共识文件重点更新版
Am J Gastroenterol. 2010 Dec;105(12):2533-49. doi: 10.1038/ajg.2010.445.
6
[The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].[抗血小板药物和非甾体抗炎药的胃肠道风险。美国心脏病学基金会（ACCF）、美国胃肠病学会（ACG）和美国心脏协会（AHA）的报告]
Recenti Prog Med. 2009 May;100(5):277-8.
7
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.ACCF/ACG/AHA 2010质子泵抑制剂与噻吩并吡啶类药物联合使用专家共识文件：ACCF/ACG/AHA 2008关于降低抗血小板治疗和非甾体抗炎药使用胃肠道风险专家共识文件的重点更新：美国心脏病学会基金会专家共识文件特别工作组报告
Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8.
8
[Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].[抗血小板药物与胃肠道出血：不经历风险，怎能战胜风险]
Ital Heart J Suppl. 2005 Oct;6(10):621-6.
9
Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.非甾体抗炎药和抗血小板药物的上消化道风险：心脏病专家的关键问题
Rev Cardiovasc Med. 2005;6 Suppl 4:S15-22.
10
[Aspirin and surgery].[阿司匹林与手术]
An R Acad Nac Med (Madr). 1997;114(4):771-92.

引用本文的文献

1
Observation of symptomatic thromboembolic events in endoscopic retrograde cholangiopancreatography patients with interruption of antithrombotic therapies.抗血栓治疗中断的内镜逆行胰胆管造影患者症状性血栓栓塞事件的观察
Front Med (Lausanne). 2025 Feb 6;12:1453026. doi: 10.3389/fmed.2025.1453026. eCollection 2025.
2
Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns.医生对质子泵抑制剂不良反应的认知与意识及其对处方模式的影响。
Front Pharmacol. 2024 Jun 26;15:1383698. doi: 10.3389/fphar.2024.1383698. eCollection 2024.
3
Time interval of esomeprazole and dual antiplatelet therapy in patients with cardiocerebrovascular diseases.
心脑血管病患者中埃索美拉唑与双联抗血小板治疗的时间间隔。
Medicine (Baltimore). 2024 Mar 1;103(9):e37205. doi: 10.1097/MD.0000000000037205.
4
Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征二级预防中 P2Y12 抑制剂致住院出血的比较风险。
Clin Pharmacol Ther. 2023 Feb;113(2):412-422. doi: 10.1002/cpt.2806. Epub 2022 Dec 28.
5
Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.某三级医院骨科手术患者应激性溃疡预防的合理性及相关因素：一项横断面研究
Front Pharmacol. 2022 Jun 2;13:881063. doi: 10.3389/fphar.2022.881063. eCollection 2022.
6
Review of Proton Pump Inhibitor Overuse in the US Veteran Population.美国退伍军人人群中质子泵抑制剂过度使用情况综述
J Pharm Technol. 2015 Aug;31(4):167-176. doi: 10.1177/8755122515575177. Epub 2015 Mar 9.
7
No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy.基于氯吡格雷、替格瑞洛或普拉格雷的双联抗血小板治疗在胃肠道出血风险方面无差异。
J Clin Med. 2020 May 18;9(5):1526. doi: 10.3390/jcm9051526.
8
Association between potentially inappropriate medications at discharge and unplanned readmissions among hospitalised elderly patients at a single centre in Japan: a prospective observational study.日本某单一中心住院老年患者出院时潜在不适当用药与非计划性再入院的相关性：一项前瞻性观察研究。
BMJ Open. 2019 Nov 7;9(11):e032574. doi: 10.1136/bmjopen-2019-032574.
9
Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: a retrospective cross-sectional study.日本某单中心急性内科疾病住院老年患者入院和出院时潜在不适当用药的患病率：一项回顾性横断面研究
BMJ Open. 2018 Jul 19;8(7):e021152. doi: 10.1136/bmjopen-2017-021152.
10
Leveraging the electronic health record to improve quality and safety in rheumatology.利用电子健康记录改善风湿病学的质量和安全性。
Rheumatol Int. 2017 Oct;37(10):1603-1610. doi: 10.1007/s00296-017-3804-4. Epub 2017 Aug 29.